Homarylamine
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
2-(1,3-benzodioxol-5-yl)-N-methylethanamine | |
| Clinical data | |
| Pregnancy category |
|
| Routes of administration | Various |
| Legal status |
|
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Biological half-life | ? |
| Excretion | ? |
| Identifiers | |
| CAS Number | 451-77-4 |
| PubChem | CID 10776 |
| ChemSpider | 10321 |
| ChEMBL | CHEMBL2104353 |
| Synonyms |
1,3-benzodioxolyl-N-methyl-5-ethanamine; 3,4-methylenedioxy-N-methyl-2-phenylethylamine |
| Chemical data | |
| Formula | C10H13NO2 |
| Molar mass | 179.21572 g/mol |
| |
| |
| (verify) | |
3,4-Methylenedioxy-N-methylphenethylamine (MDMPEA), also known as homarylamine (INN), is an entactogen, psychedelic, and stimulant of the phenethylamine chemical class. It is the N-methylated analogue of MDPEA. Very little is known about the pharmacology, pharmacokinetics, effects, and toxicity of MDMPEA.
See also
References
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
